Literature DB >> 23650357

Combined effect of a peptide-morpholino oligonucleotide conjugate and a cell-penetrating peptide as an antibiotic.

Donna Wesolowski1, Dulce Alonso, Sidney Altman.   

Abstract

A cell-penetrating peptide (CPP)-morpholino oligonucleotide (MO) conjugate (PMO) that has an antibiotic effect in culture had some contaminating CPPs in earlier preparations. The mixed conjugate had gene-specific and gene-nonspecific effects. An improved purification procedure separates the PMO from the free CPP and MO. The gene-specific effects are a result of the PMO, and the nonspecific effects are a result of the unlinked, unreacted CPP. The PMO and the CPP can be mixed together, as has been shown previously in earlier experiments, and have a combined effect as an antibiotic. Kinetic analysis of these effects confirm this observation. The effect of the CPP is bacteriostatic. The effect of the PMO appears to be bacteriocidal. An assay for mutations that would alter the ability of these agents to affect bacterial viability is negative.

Entities:  

Keywords:  EGS technology; RNase P; gram-negative bacteria; gram-positive bacteria

Mesh:

Substances:

Year:  2013        PMID: 23650357      PMCID: PMC3666680          DOI: 10.1073/pnas.1306911110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

Review 2.  Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

Authors:  Kim A Brogden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

3.  External guide sequences for an RNA enzyme.

Authors:  A C Forster; S Altman
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

4.  Basic peptide-morpholino oligomer conjugate that is very effective in killing bacteria by gene-specific and nonspecific modes.

Authors:  Donna Wesolowski; Hyun Seop Tae; Neeru Gandotra; Paula Llopis; Ning Shen; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

5.  Gene selective mRNA cleavage inhibits the development of Plasmodium falciparum.

Authors:  Yoann Augagneur; Donna Wesolowski; Hyun Seop Tae; Sidney Altman; Choukri Ben Mamoun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

6.  Mu dX, a derivative of Mu d1 (lac Apr) which makes stable lacZ fusions at high temperature.

Authors:  T A Baker; M M Howe; C A Gross
Journal:  J Bacteriol       Date:  1983-11       Impact factor: 3.490

7.  Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation.

Authors:  Je-Min Choi; Jae-Hun Shin; Myung-Hyun Sohn; Martha J Harding; Jong-Hyun Park; Zuzana Tobiasova; Da-Young Kim; Stephen E Maher; Wook-Jin Chae; Sung-Ho Park; Chun-Geun Lee; Sang-Kyou Lee; Alfred L M Bothwell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

8.  Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.

Authors:  Saïd Abes; Hong M Moulton; Philippe Clair; Paul Prevot; Derek S Youngblood; Rebecca P Wu; Patrick L Iversen; Bernard Lebleu
Journal:  J Control Release       Date:  2006-09-30       Impact factor: 9.776

9.  Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo.

Authors:  Brett L Mellbye; Dwight D Weller; Jed N Hassinger; Matthew D Reeves; Candace E Lovejoy; Patrick L Iversen; Bruce L Geller
Journal:  J Antimicrob Chemother       Date:  2010-01       Impact factor: 5.790

10.  Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.

Authors:  Brett L Mellbye; Susan E Puckett; Luke D Tilley; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

View more
  10 in total

1.  Targeting protein translation, RNA splicing, and degradation by morpholino-based conjugates in Plasmodium falciparum.

Authors:  Aprajita Garg; Donna Wesolowski; Dulce Alonso; Kirk W Deitsch; Choukri Ben Mamoun; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

Review 2.  External guide sequence technology: a path to development of novel antimicrobial therapeutics.

Authors:  Carol Davies-Sala; Alfonso Soler-Bistué; Robert A Bonomo; Angeles Zorreguieta; Marcelo E Tolmasky
Journal:  Ann N Y Acad Sci       Date:  2015-04-09       Impact factor: 5.691

3.  Photophysicochemical, calf thymus DNA binding and in vitro photocytotoxicity properties of tetra-morpholinoethoxy-substituted phthalocyanines and their water-soluble quaternized derivatives.

Authors:  Halit Koçan; Kerem Kaya; İbrahim Özçeşmeci; B Şebnem Sesalan; Meltem Göksel; Mahmut Durmuş; Ayfer Kalkan Burat
Journal:  J Biol Inorg Chem       Date:  2017-10-19       Impact factor: 3.358

4.  A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells.

Authors:  Alexandra Antonoplis; Xiaoyu Zang; Melanie A Huttner; Kelvin K L Chong; Yu B Lee; Julia Y Co; Manuel R Amieva; Kimberly A Kline; Paul A Wender; Lynette Cegelski
Journal:  J Am Chem Soc       Date:  2018-11-14       Impact factor: 15.419

5.  Medium effects on minimum inhibitory concentrations of nylon-3 polymers against E. coli.

Authors:  Heejun Choi; Saswata Chakraborty; Runhui Liu; Samuel H Gellman; James C Weisshaar
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

6.  Regulation of Hfq mRNA and protein levels in Escherichia coli and Pseudomonas aeruginosa by the Burkholderia cenocepacia MtvR sRNA.

Authors:  Christian G Ramos; André M Grilo; Sílvia A Sousa; Joana R Feliciano; Paulo J P da Costa; Jorge H Leitão
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

Review 7.  Silencing Antibiotic Resistance with Antisense Oligonucleotides.

Authors:  Saumya Jani; Maria Soledad Ramirez; Marcelo E Tolmasky
Journal:  Biomedicines       Date:  2021-04-12

Review 8.  RNase P-Mediated Sequence-Specific Cleavage of RNA by Engineered External Guide Sequences.

Authors:  Merel Derksen; Vicky Mertens; Ger J M Pruijn
Journal:  Biomolecules       Date:  2015-11-09

Review 9.  Antisense antimicrobial therapeutics.

Authors:  Erin K Sully; Bruce L Geller
Journal:  Curr Opin Microbiol       Date:  2016-06-29       Impact factor: 7.934

10.  Rationally designing antisense therapy to keep up with evolving bacterial resistance.

Authors:  Seyfullah Kotil; Eric Jakobsson
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.